PROGNOSTIC FACTORS AND SURVIVAL IN MULTIPLE-MYELOMA - ANALYSIS OF 91 CASES TREATED BY MELPHALAN AND PREDNISONE

被引：0
|
作者：
GOBBI, M
CAVO, M
SAVELLI, G
BACCARANI, M
TURA, S
机构：
[1] UNIV BOLOGNA,CATTEDRA EMATOL,I-40126 BOLOGNA,ITALY
[2] UNIV TRIESTE,INSEGNAMENTO EMATOL,I-34127 TRIESTE,ITALY
来源：
HAEMATOLOGICA | 1980年 / 65卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：437 / 445
页数：9
相关论文
共 50 条
  • [41] PROGNOSTIC FACTORS IN MULTIPLE-MYELOMA - CRITICAL ANALYSIS IN 84 PATIENTS
    BENITEZ, O
    DEGRAMONT, A
    HUBERT, D
    SIRINELLI, A
    BRISSAUD, P
    SMADJA, N
    KRULIK, M
    DEBRAY, J
    SEMAINE DES HOPITAUX, 1984, 60 (40): : 2791 - 2794
  • [42] A RANDOMIZED TRIAL OF MAINTENANCE VERSUS NO MAINTENANCE MELPHALAN AND PREDNISONE IN RESPONDING MULTIPLE-MYELOMA PATIENTS
    BELCH, A
    SHELLEY, W
    BERGSAGEL, D
    WILSON, K
    KLIMO, P
    WHITE, D
    WILLAN, A
    BRITISH JOURNAL OF CANCER, 1988, 57 (01) : 94 - 99
  • [43] MELPHALAN-PREDNISONE-CYCLOPHOSPHAMIDE (MP+C) VS MP FOR MULTIPLE-MYELOMA
    GIBBS, G
    KIANG, DT
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 373 - 373
  • [44] CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISONE AND VINDESINE COMBINATION CHEMOTHERAPY IN MELPHALAN-RESISTANT MULTIPLE-MYELOMA
    VANDOBBENBURGH, OA
    HOUWEN, B
    PIERSMA, H
    MARRINK, J
    OCKHUIZEN, T
    HALIE, MR
    NIEWEG, HO
    NETHERLANDS JOURNAL OF MEDICINE, 1984, 27 (02): : 25 - 30
  • [45] MULTIPLE-MYELOMA - RESULTS FROM TREATMENT OF 50 PATIENTS RECEIVING MELPHALAN-PREDNISONE-PROCARBAZINE (MPP) OR MELPHALAN-PREDNISONE (MP)
    LIRA, P
    WALKER, B
    GREBE, G
    REVISTA MEDICA DE CHILE, 1985, 113 (06) : 8 - 8
  • [46] MONOCHEMOTHERAPY (MELPHALAN + PREDNISONE) VERSO POLYCHEMOTHERAPY ALTERNATA (VMCP/VBAP) NEL MULTIPLE-MYELOMA
    MUSTO, P
    BAVARO, P
    BODENIZZA, C
    MELILLO, L
    CAROTENUTO, M
    TUMORI, 1986, 72 (06) : 720 - 720
  • [47] EFFECTIVENESS OF 2-STAGE TREATMENT OF MULTIPLE-MYELOMA WITH MELPHALAN AND WITH MELPHALAN IN COMBINATION WITH CYCLOPHOSPHAMIDE, CARMUSTINE, VINCRISTINE AND PREDNISONE
    SNIGUROWICZ, J
    KRAJ, M
    ROSTKOWSKA, J
    MAJ, S
    MARIANSKA, B
    MENDEK, E
    ROSZKOWSKI, S
    KILIAN, Z
    KOLAKOWSKI, L
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 1981, 29 (02) : 145 - 153
  • [48] PROGNOSTIC FACTORS IN MULTIPLE-MYELOMA - REVIEW OF THE LITERATURE
    BAUDUER, F
    TROUSSARD, X
    DELMER, A
    BULLETIN DU CANCER, 1993, 80 (12) : 1035 - 1042
  • [49] MULTIPLE-MYELOMA - PROGNOSTIC FACTORS AND TREATMENT MODALITIES
    MICHIELS, JJ
    NETHERLANDS JOURNAL OF MEDICINE, 1992, 40 (5-6): : 254 - 270
  • [50] LYMPHOID SUBSETS AND PROGNOSTIC FACTORS IN MULTIPLE-MYELOMA
    SANMIGUEL, JF
    GONZALEZ, M
    GASCON, A
    MORO, MJ
    HERNANDEZ, JM
    ORTEGA, F
    JIMENEZ, R
    GUERRAS, L
    ROMERO, M
    CASANOVA, F
    SANZ, MA
    SANCHEZ, J
    PORTERO, JA
    ORFAO, A
    BRITISH JOURNAL OF HAEMATOLOGY, 1992, 80 (03) : 305 - 309
12345